Emerging roles of miRNAs in the development of pancreatic cancer

Mohadeseh Fathi1, Soudeh Ghafouri-Fard1, Atefe Abak2

  • 1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

MicroRNAs (miRNAs) play a dual role in pancreatic cancer, with some promoting tumor growth and others suppressing it. These epigenetic factors show promise as non-invasive diagnostic and prognostic markers for pancreatic cancer.

Area of Science:

  • * Molecular Oncology
  • * Epigenetics
  • * Cancer Biology

Background:

  • * Pancreatic cancer is a leading cause of cancer mortality, projected to become the third leading cause by 2025.
  • * Genetic mutations (KRAS, TP53, etc.) and epigenetic alterations drive pancreatic cancer development.
  • * MicroRNAs (miRNAs) are key epigenetic regulators implicated in various cancers, including pancreatic cancer.

Purpose of the Study:

  • * To elucidate the dual role of oncomiRs and tumor suppressor miRNAs in pancreatic cancer evolution.
  • * To review the diagnostic and prognostic potential of miRNAs in pancreatic cancer.
  • * To highlight miRNAs as potential non-invasive biomarkers for early detection and patient management.

Main Methods:

  • * Comprehensive literature review of studies investigating miRNA roles in pancreatic cancer.
  • * Analysis of identified oncomiRs and tumor suppressor miRNAs affecting cancer cell proliferation and apoptosis.
  • * Evaluation of miRNA expression profiles for diagnostic and prognostic applications.

Main Results:

  • * Specific oncomiRs (e.g., miR-212, miR-506, miR-196b) promote pancreatic cancer cell proliferation and inhibit apoptosis.
  • * Tumor suppressor miRNAs (e.g., miR-451a, miR-142, miR-340) modulate cell proliferation and cell cycle progression.
  • * miRNAs demonstrate potential as sensitive and specific non-invasive biomarkers for pancreatic cancer detection and prognosis.

Conclusions:

  • * MicroRNAs are critical epigenetic regulators in pancreatic cancer, acting as both oncomiRs and tumor suppressors.
  • * Dysregulation of specific miRNAs contributes to pancreatic cancer pathogenesis.
  • * miRNAs hold significant promise as novel, non-invasive diagnostic and prognostic tools for pancreatic cancer, facilitating earlier detection and improved patient outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K